Enter assignee name

EPO Patents = 3

Trademarks = 2

Forward Citations = 7

Loading Chart...

10 inventors (with patents filed for the assignee):

Sandra P Morales (7 out of 7 patents)

Gillian Mearns (5 out of 5 patents)

Deborah A Rankin (5 out of 5 patents)

4. Frenk Smrekar (5 out of 5 patents)

5. Karen Joy Shaw (3 out of 3 patents)

6. Brian C Varnum (1 out of 9 patents)

7. Igor P Bilinsky (1 out of 1 patent)

8. Stacey Lynn Kolar (1 out of 1 patent)

9. Sebastien Lemire (1 out of 1 patent)

10. David R Harper (7 patents)

11. Katy Blake (1 patent)

12. Sandra P Morales (0 patent)

13. Sandra P Morales (0 patent)

7 patents: Sort by Forward Citations

1. 12594312 - Bacteriophage compositions for treatinginfection (2026-04-07),

2. 12503687 - Therapeutic bacteriophage compositions (2025-12-23),

3. 12268720 - Bacteriophage for treatment and prevention ofandinfections (2025-04-08),

4. 12239677 - Therapeutic bacteriophage compositions for treatinginfection (2025-03-04),

5. 11654166 - Therapeutic bacteriophage compositions for treatinginfection (2023-05-23),

6. 11253557 - Therapeutic bacteriophage compositions (2022-02-22),

7. 10517908 - Therapeutic bacteriophage compositions (2019-12-31),

Armata Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing innovative therapies for patients with infectious diseases. The company's proprietary bacteriophage platform enables the design of treatments targeting antibiotic-resistant bacterial infections. By harnessing the natural ability of bacteriophages, Armata aims to provide effective solutions against pathogens that pose significant challenges to public health. Armata's lead product candidates are designed to address serious medical needs, particularly in the hospital setting, and the company continues to expand its research and development initiatives to create novel therapies for unmet needs in infectious disease management.

Profile summary based on public USPTO records.